Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genome-wide approach to identify risk factors for therapy-related myeloid leukemia.

Leukemia - 1 Feb 2006

Bogni A, Cheng C, Liu W, Yang W, Pfeffer J, Mukatira S, French D, Downing J R, Pui C-H, Relling M V

Abstract excerpt

Using a target gene approach, only a few host genetic risk factors for treatment-related myeloid leukemia (t-ML) have been defined. Gene expression microarrays allow for a more genome-wide approach to assess possible genetic risk factors for t-ML. We assessed gene expression profiles (n=12 625 probe sets) in diagnostic acute lymphoblastic leukemic cells from 228 children treated on protocols that included...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cluster Analysis
Share to Follow-Up Studies
Share to Leukemia, Myeloid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasms, Second Primary

Share to Oligonucleotide Array Sequence Analysis

Share to Precursor Cell Lymphoblastic Leukemia-Lymphoma

Share to Regression Analysis

Share to RNA, Neoplasm

Source

Identifiers

PMID: 16341039
DOI: 10.1038/sj.leu.2404059

Genes

ARNT
CCND1
CCNG1
CCNG2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genome-wide approach to identify risk factors for therapy-related myeloid leukemia.PMID 16341039Read ↗

Linking genomic lesions with minimal residual disease improves prognostic stratification in children with T-cell acute lymphoblastic leukaemia.Semantic proximity Read ↗

Genomics of therapy-related myeloid neoplasmsSemantic proximity Read ↗

DNA methylation for subtype classification and prediction of treatment outcome in patients with childhood acute lymphoblastic leukemiaSemantic proximity Read ↗

Genomic approaches to hematologic malignanciesSemantic proximity Read ↗

Genome-wide association study to identify novel loci associated with therapy-related myeloid leukemia susceptibility.Semantic proximity Read ↗

Gene expression profiling of pediatric acute myelogenous leukemiaSemantic proximity Read ↗

Genome‐wide analysis of acute myeloid leukemia with normal karyotype reveals a unique pattern of homeobox gene expression distinct from those with translocation‐mediated fusion eventsSemantic proximity Read ↗

Identification of a gene expression signature associated with pediatric AML prognosisSemantic proximity Read ↗

Gene expression profiling in MDS and AML: potential and future avenuesSemantic proximity Read ↗

Identification of genomic classifiers that distinguish induction failure in T-lineage acute lymphoblastic leukemia: a report from the Children's Oncology GroupSemantic proximity Read ↗

Polygenic Ara-C Response Score Identifies Pediatric Patients With Acute Myeloid Leukemia in Need of Chemotherapy Augmentation.Semantic proximity Read ↗

Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leukemia with inv(14)(q11q32).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.